Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Hiooletsgobio's Profile
Displaying 1-7 of 7 result(s).
PMCB PharmaCyte Biotech Inc.
02/07/2018 11:59:25 PM
http://pharmabypharmd.com/amicus-t
FOLD Amicus Therapeutics Inc.
02/07/2018 11:56:19 PM
Nice article on FOLD http://pharmab
Investors Hangout MVP's
01/09/2018 12:18:39 AM
Nice site to scoop biotech news- ph
ALERTS, HOT STOCKS & CHARTS
12/29/2017 1:08:21 AM
$AXSM nice article http://pharmabyp
Investors Hangout MVP's
12/23/2017 7:20:34 PM
Liking drug and new ceo
Investors Hangout MVP's
12/23/2017 6:56:05 PM
SGYP- nice drug, seems undervalued-
SGYPQ Synergy Pharmaceuticals, Inc.
12/23/2017 6:49:58 PM
SGYP- Undervalued http://pharmabyph (1)

Recent Articles

  • Constellium's Innovations Shine at the Paris Air Show 2025
  • Roche Moves Forward with Prasinezumab for Early-Stage Parkinson's
  • Rolf Gobet Joins WISeKey's Advisory Committee on Strategy
  • PingPong Introduces InvestXB: A Game Changer for Investors
  • Exploring the Rise of U.S. Latinos and Their Brand Expectations
  • Revolutionizing Aircraft Performance with GTF Hot Section Plus
  • Queclink Strengthens European Operations with New Office
  • Tencent Cloud Enhances AI Capabilities for European Enterprises
  • Queclink Strengthens European Market with New Office Venture
  • Jingle Pay Partners with Western Union for Global Transfers
  • Ursa Major's New Hypersonic Engine Contract Boosts National Defense
  • PayPal's Innovative Storefront Ads: Revolutionizing E-Commerce Reach
  • Innovative AI Multimodal Learning Platform Set to Transform Learning
  • Empowering Africa's Children Through Quality Education Initiatives
  • Exploring the Evolution of Urban-Rural Transport in China
  • DDB Capital Enhances Investment Focus in North Alabama Housing
  • Anticipation Grows for the 2nd China-Central Asia Summit
  • Revitalizing Heritage: A Journey Through Dunhuang's Culture
  • Abbisko Therapeutics Advances Irpagratinib Study for HCC Treatment
  • China to Host 6th Multinationals Summit, Encouraging Investment
  • SDP Japan Secures $31 Million to Transform Surgical Care
  • Tokyo Gas Triumphs in Cloud Native Case Study Competition
  • Significant Subgroup Analysis of Cadonilimab in Cervical Cancer
  • Stavian Chemical Achieves Major Milestone in Global Rankings
  • ArkBio's Azstarys Approved for ADHD Treatment Review in China
  • Strategic Thinking in China's Development Plans and Governance
  • Industrial Lubricants: Insights and Future Market Trends Ahead
  • Innovent's Mazdutide Advances with First Patient Dosed in Trial
  • Innovative Treatment Strategies Highlighted at EHA 2025 Conference
  • Celltrion Gains FDA Nod for New STEQEYMA® Pediatric Formulation
  • Innovative Drug Screening Services Introduced by Samsung Biologics
  • Transforming Transit: $4 Billion to Electrify Buses in Canada
  • Abaxx Technologies Launches Innovative Gold Futures Trading
  • 2025 Meijer LPGA Classic Makes Impact with $1.5 Million
  • Bombardier's Global 7500 Establishes New Speed Benchmark
  • IDEX Biometrics ASA Announces Significant Share Issuance to Personnel
  • Investors Urged to Join Class Action Against West Pharmaceutical Services
  • Honoring Leonard A. Lauder: A Legacy in Alzheimer's Research
  • Elevate Your Earnings with PFMCrypto's Exciting XRP Giveaway
  • AIXA Miner Celebrates Groundbreaking Milestone in Green Mining
  • Oma Savings Bank Plc Revises Profit Outlook: Important Update
  • Transformative Leadership Change at Renault Group Announced
  • Deadline for Fortrea Holdings Inc. Investors in Lawsuit Ahead
  • Dupixent® Triumphs in Phase 4 Trial Against Xolair® for CRSwNP
  • Dupixent vs. Xolair: Breakthrough Findings in Asthma Treatment
  • Faruqi & Faruqi Investigates Ibotta's Legal Claims for Investors
  • Red Cat Holdings Faces Legal Challenges Amid Investor Concerns
  • Investor Alert: Key Updates on Iovance Biotherapeutics Lawsuit
  • Investors Alert: Faruqi & Faruqi Advocate for Open Lending Claims
  • Compass Diversified Investors Encouraged to Act Before Deadline
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site